This news item contains updated data on the evolution of the COVID-19 pandemic, obtained from various official sources, especially from the Ministry of Health and the Autonomous Communities, as well as from various international media such as Johns Hopkins University, the WHO and the European Medicines Agency. Update of COVID cases in Spain. Data updated […]
Read More
ECDC-EMA statement on booster vaccination with Omicron adapted bivalent COVID-19 vaccines
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have issued a joint statement providing updated public health considerations on the use of the newly authorised adapted COVID-19 vaccines to support the planning of the autumn and winter vaccination campaigns. The EU has recently extended its arsenal with two new updated vaccines, Comirnaty […]
Read More
COVID-19 evolution in America
This news item shows updated data, obtained from Johns Hopkins University, concerning the incidence of diagnosed cases and deaths from the COVID-19 virus in America. As of September 06, 2022, a total of 196,578 daily cases of COVID-19 have been diagnosed in the Americas in the last 7 days, with the countries with the highest […]
Read More
Commission rallies Member States to prepare for autumn and winter
The Commission is proposing concrete measures to avoid a surge of COVID-19 cases in the upcoming autumn and winter season. The Commission is urging Member States to put the necessary strategies and structures in place, including for COVID-19 vaccination and surveillance, to respond to future outbreaks in a fast and sustained manner. The main aim of […]
Read More
First adapted COVID-19 booster vaccines recommended for approval in the EU
EMA’s human medicines committee (CHMP) has recommended authorising two vaccines adapted to provide broader protection against COVID-19. Comirnaty Original/Omicron BA.1 and Spikevax Bivalent Original/Omicron BA.1 are for use in people aged 12 years and above who have received at least primary vaccination against COVID-19. These vaccines are adapted versions of the original vaccines Comirnaty (Pfizer/BioNTech) […]
Read More
Commission decides to register new European Citizens’ Initiative on tobacco
The Commission decided to register a European Citizens’ Initiative (ECI) entitled ‘Call to achieve a tobacco-free environment and the first European tobacco-free generation by 2030′. The organisers of the initiative call on the Commission to propose legislation to save new generations from falling into tobacco addiction, to act against related environmental dangers and against smoking. […]
Read More
EMA advises on intradermal use of Imvanex / Jynneos against monkeypox
The European Medicines Agency (EMA) has advised on intradermal use of monkeypox vaccine. EMA’s Emergency Task Force (ETF) has reviewed data showing that people who receive the monkeypox vaccine as an intradermal injection (injection into the skin) produce similar levels of antibodies to those who receive it as a subcutaneous injection (injection under the skin). As only […]
Read More
Coronavirus Present Situation in Africa
This news item shows updated data, obtained from various official sources (Johns Hopkins University, Reuters, WHO…), on the incidence of diagnosed cases and deaths due to the COVID-19 virus in Africa. Countries with the highest average incidence of cases diagnosed in the last 7 days Looking at the data as of August 19, 2022, […]
Read More
Joint Procurement contract HIPRA for Covid-19
HERA, the European Commission’s Health Preparedness and Response Authority, has signed a joint procurement Framework Contract with the company HIPRA HUMAN HEALTH for the supply of their protein COVID-19 vaccine. 14 Member States and countries are participating in this joint procurement, under which they can purchase up to 250 million doses. As the number of cases is […]
Read More